| AIM2 | Absent in melanoma 2 |
| ASC | Apoptosis-associated speck-like protein containing a CARD complex |
| ATP | Adenosine triphosphate |
| CARD | Caspase activation and recruitment domain |
| CASP-1 | Caspase-1 |
| CCDN1 | Cyclin D1 |
| DAMP | Damage-associated molecular patterns |
| ECL | Enhanced chemiluminescence |
| EMT | Epithelial–mesenchymal transition |
| ERK | Extracellular signal regulated kinase |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| IL | Interleukin |
| IL-1β | Interleukin-1β |
| LRR | Leucine-rich repeat |
| MMP | Matrix metallopeptidases |
| NLR | Nucleotide-binding domain-like receptors |
| NLRC4 | NLR Family CARD Domain Containing 4 |
| NLRP1 | NOD-, LRR- and pyrin domain-containing protein 1 |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| NOD | Nucleotide-binding oligomerization domain |
| NP-40 | Nonylphonoxypolyethoxypthanol-40 |
| PBS | Phosphate-buffered saline |
| P2X7R | P2X purinergic receptor 7 |
| P2Y2R | P2Y purinergic receptor 2 |
| PAMP | Pathogen-associated molecular pattern |
| PI3K | Phosphatidylinositol 3-kinase |
| RIPA | Radioimmunoprecipitation assay |
| RPMI | Roswell Park Memorial Institute |
| RT-R | Radiotherapy-resistant |
| TNF-α | Tumor necrosis factor-α |
| TNM | Tumor-node-metastasis |
| VEGF | Vascular endothelial growth factor |
| VEGF-A | Vascular endothelial growth factor-A |
| VEGFR | Vascular endothelial growth factor receptor |